Advertisement

Topics

Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin / metformin hydrochloride, Revision: 13, Authorised

06:00 EDT 2 Aug 2017 | European Medicines Agency

Original Article: Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin / metformin hydrochloride, Revision: 13, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin / metformin hydrochloride, Revision: 13, Authorised"

Quick Search
Advertisement